We extract the circulating, cell-free DNA (cfDNA) that are expelled by the cells in your body from a sample of your blood. Tumor cells expel cfDNA with mutations associated with cancer called circulating tumor DNA (ctDNA). Using specialized, proprietary biotechnology and machine learning computational algorithms, we detect the ctDNA using real-time next-generation sequencing. Our specialized pipeline is able to detect novel mutations, copy number variations and translocations that allow us to accurately diagnose many different types of cancer and the best potential treatment course based on the complete genetic composition of the whole tumor.